Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Francesca Castellaneta"'
Autor:
Luigi Santacroce, Lucrezia Bottalico, Ioannis Alexandros Charitos, Francesca Castellaneta, Elona Gaxhja, Skender Topi, Raffaele Palmirotta, Emilio Jirillo
Publikováno v:
Antioxidants, Vol 13, Iss 7, p 796 (2024)
Daily, a lot of food is wasted, and vegetables, fruit, and cereals as well as marine products represent the major sources of unwanted by-products. The sustainability, waste recovery, and revalorization of food by-products have been proposed as the ma
Externí odkaz:
https://doaj.org/article/86183d19140f4b3f838a36e1270f73d5
Autor:
Davide Gnocchi, Laura Del Coco, Chiara Roberta Girelli, Francesca Castellaneta, Gianluigi Cesari, Carlo Sabbà, Francesco Paolo Fanizzi, Antonio Mazzocca
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Hepatocellular carcinoma (HCC) is nowadays the sixth cause of tumour-related deceases worldwide, estimated to become the third in Western countries by 2030. New drugs for HCC treatment still have many adverse effects. Several lines of eviden
Externí odkaz:
https://doaj.org/article/0b72afd049f04d0e9d440906be138b84
Autor:
Donato D’Agostino, Giangiuseppe Cappabianca, Crescenzia Rotunno, Francesca Castellaneta, Teresa Quagliara, Alessandro Carrozzo, Florinda Mastro, Ioannis Alexandros Charitos, Cesare Beghi, Domenico Paparella
Publikováno v:
Antibiotics, Vol 8, Iss 4, p 176 (2019)
Aims: There are many reasons for the increase in post-operative mortality and morbidity in patients undergoing surgery. In fact, an activated inflammatory state before cardiac surgery, can potentially worsen the patient’s prognosis and the effects
Externí odkaz:
https://doaj.org/article/8b5e3014810d4fe8bc5deb8007e2becc
Publikováno v:
Antibiotics, Vol 8, Iss 2, p 56 (2019)
In the area of Emergency Room (ER), many patients present criteria compatible with a SIRS, but only some of them have an associated infection. The new definition of sepsis by the European Society of Intensive Care Medicine and the Society of Critical
Externí odkaz:
https://doaj.org/article/12f5b15f51b44138b7836bdffe482d76
Autor:
Roberto Arrigoni, Rosa Porro, Mario Dioguardi, Filiberto Mastrangelo, Angela Pia Cazzolla, Francesca Castellaneta, Ioannis Alexandros Charitos, Stefania Cantore, Michele Covelli
Publikováno v:
Open Access Macedonian Journal of Medical Sciences. 10:758-762
BACKGROUND: Rosalind Franklin was a British scientist in the 1950s, that in her short career covered a lot of important scientific topics, ranging from coal structure porosity, to biological molecules cristallography, and finally to viruses structure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ba9a41786c44ee98f6d911faa72e2fb
https://doi.org/10.3889/oamjms.2022.10705
https://doi.org/10.3889/oamjms.2022.10705
Autor:
Ioannis Alexandros Charitos, Andrea Ballini, Roberto Lovero, Francesca Castellaneta, Marica Colella, Salvatore Scacco, Stefania Cantore, Roberto Arrigoni, Filiberto Mastrangelo, Mario Dioguardi
Publikováno v:
International journal of environmental research and public health. 19(17)
The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, the economy, and society. When SARS-CoV-2 began to spread, the most recent serious infectious disease of this century around the world, with its high morbidity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f521c0f1bc582fe6dd0bc0cceffe3d
https://pubmed.ncbi.nlm.nih.gov/36078427
https://pubmed.ncbi.nlm.nih.gov/36078427
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 21:801-814
Aim: Investigating about the history of allergies and discovery of the histamine’s role in the immune response through historical references, starting with ancient anecdotes, analysing the first immunization attempts on animals to understand its im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00071ab433937159fdee9dbeb9ef3829
https://doi.org/10.2174/1871530320666200729150124
https://doi.org/10.2174/1871530320666200729150124
Autor:
Ioannis Alexandros Charitos, Francesca Castellaneta, Skender Topi, Lucrezia Bottalico, Luigi Santacroce
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 20:335-343
Background: There is not a time in the history when epidemics did not loom large: infectious diseases have always had civilisation and evolution-altering consequences. Throughout history, there have been a number of pandemics: cholera, bubonic plague
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::156ba81742291d1c0661ae6715863c73
https://doi.org/10.2174/1871530319666191009144217
https://doi.org/10.2174/1871530319666191009144217
Autor:
Francesca Castellaneta, Antonio Mazzocca, Chiara Roberta Girelli, Gianluigi Cesari, Davide Gnocchi, Francesco Paolo Fanizzi, Carlo Sabbà, Laura Del Coco
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Hepatocellular carcinoma (HCC) is nowadays the sixth cause of tumour-related deceases worldwide, estimated to become the third in Western countries by 2030. New drugs for HCC treatment still have many adverse effects. Several lines of evidence indica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::288506d0130f45851729d513ba4d7458
https://hdl.handle.net/11587/447683
https://hdl.handle.net/11587/447683
Autor:
Giorgio Fiore, Carlo Sabbà, Antonio Mazzocca, Davide Gnocchi, Francesca Castellaneta, Gianluigi Cesari
Publikováno v:
The Journal of pharmacy and pharmacology. 73(10)
Objectives Hepatocellular carcinoma (HCC) is one of the most frequent tumours worldwide and available drugs are inadequate for therapeutic results and tolerability. Hence, novel effective therapeutic tools with fewer side effects are of paramount imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2f5fce68c8899a490bc4522bbfb6603
https://pubmed.ncbi.nlm.nih.gov/34014301
https://pubmed.ncbi.nlm.nih.gov/34014301